Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 3 | 1548 | 86 | 0.4218 | 0.6073 | 0.0556 | 0.0523 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 1 | 1962 | 107 | 0.5351 | 0.4191 | 0.0545 | 0.0616 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 2 | 1617 | 91 | 0.4402 | 0.4191 | 0.0563 | 0.0616 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 3 | 1055 | 78 | 0.2819 | 0.4191 | 0.0739 | 0.0616 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 1598 | 96 | 0.4333 | 0.5367 | 0.0601 | 0.0669 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 2 | 2275 | 142 | 0.6153 | 0.5367 | 0.0624 | 0.0669 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2111 | 165 | 0.5614 | 0.5367 | 0.0782 | 0.0669 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 1 | 1900 | 105 | 0.5178 | 0.5749 | 0.0553 | 0.0526 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 2 | 2177 | 113 | 0.5954 | 0.5749 | 0.0519 | 0.0526 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 3 | 2232 | 113 | 0.6113 | 0.5749 | 0.0506 | 0.0526 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 2285 | 94 | 0.6321 | 0.4655 | 0.0411 | 0.0405 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 2 | 1741 | 82 | 0.4786 | 0.4655 | 0.0471 | 0.0405 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 3 | 1025 | 34 | 0.2859 | 0.4655 | 0.0332 | 0.0405 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 1 | 1353 | 87 | 0.3652 | 0.3125 | 0.0643 | 0.0644 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 2 | 1387 | 78 | 0.3776 | 0.3125 | 0.0562 | 0.0644 |
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 3 | 728 | 53 | 0.1947 | 0.3125 | 0.0728 | 0.0644 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1404 | 173 | 0.3551 | 0.4243 | 0.1232 | 0.1334 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 2 | 1852 | 251 | 0.4619 | 0.4243 | 0.1355 | 0.1334 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1840 | 260 | 0.4558 | 0.4243 | 0.1413 | 0.1334 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 1 | 1150 | 122 | 0.2966 | 0.3680 | 0.1061 | 0.0865 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 2 | 1413 | 126 | 0.3713 | 0.3680 | 0.0892 | 0.0865 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 3 | 1616 | 104 | 0.4362 | 0.3680 | 0.0644 | 0.0865 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1888 | 167 | 0.4965 | 0.3742 | 0.0885 | 0.0960 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 2 | 1496 | 141 | 0.3909 | 0.3742 | 0.0943 | 0.0960 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 911 | 96 | 0.2351 | 0.3742 | 0.1054 | 0.0960 |